World Conference on Lung Cancer
Check out our dedicated conference page for expert interviews and highlighted coverage from the latest conference presentations.
Latest News
View All
Refined iRR6 Model Improves Risk Stratification in Intermediate-1 Myelofibrosis
Team Coordination, Data Sharing Help Prioritize Value in Cardio-Renal-Metabolic Care
Indirect Comparison Finds Zanubrutinib Associated With Better PFS, OS Than Acalabrutinib in MCL
Driving Healthier Outcomes Through Comprehensive, Team-Based Care: Q&A With Marisa Rogers, MD, MPH
Women Still Underrepresented in Key Cardiovascular Trials
Food Insecurity Associated With Increased Long COVID Risk, Lower Recovery Rates
Employers Lean on Data Transparency to Contain Rising Health Care Costs
Q&A Part 2: UPMC Health Plan Dental Care Managers Forging Community Relationships
Advancing Myasthenia Gravis Treatment Access via Guideline-Directed Expertise
Decline in US Pediatric Radiology Workforce Raises Concerns About Specialized Imaging Access
Medicare Advantage Patients More Likely to Experience Extended Hospital Stays Post COVID-19
Overcoming Barriers to Widespread Neoadjuvant Lung Cancer Testing: Sandip Patel, MD
BMI Screening Overlooks Excess Adiposity in Children Without Obesity
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Empowering Health Care Professionals: Training and Resources for Diverse AD Care
Potential Impact of Emerging Therapies on Patients Living with ITP
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
Access, Adaptation, and Cost-Effectiveness in AD Treatment
Rebuilding Trust in Medical Care Is Paramount as Children Potentially Lose Medicaid Coverage: Chris Johnson, MBA
Survivorship Care and the Provider’s Role in Patient Support: Adriana Olivo, NP
Navigating Cilta-Cel Sequencing in Multiple Myeloma: Surbhi Sidana, MD, MBBS
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Recognizing and Testing for ROS1 in NSCLC
Analyzing the Safety Data of JAK Inhibitors
Value-Based Care Veterans, Surprised by EOM Results, Ponder Next Move
Updated MARIPOSA Data Highlight Clinical Impact of Upfront Dual Inhibition in EGFR+ NSCLC
Enhanced Prophylactic Regimen Reduces Skin AEs With Amivantamab-Lazertinib: Byoung Chul Cho, MD, PhD
PALOMA-2 Reinforces Efficacy of SubQ Amivantamab in EGFR-Mutated NSCLC: Sun Lim Min, MD, PhD
Team Coordination, Data Sharing Help Prioritize Value in Cardio-Renal-Metabolic Care
Mitigating Cardiometabolic Risk Through Therapies, Weight Management
Safeguarding Patient Health Through Value-Based Systems Integration
Navigating Compounded Semaglutide: What Health Care Providers Need to Know
Impact of More Primary Care Visits on Commercial Health Care Costs
State Restrictions on Prior Authorization
Remote Clinical Pharmacists Saved Nearly $9M, Helped Practices Meet EOM Targets
Many Uncertainties With New Cancer Drugs Don’t Make it to FDA Label, Study Finds
Through AHIP, Payers Vow to Rein in Prior Authorization, but Doctors Have Doubts
Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)
From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape
Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities in Metastatic HER2+ Breast Cancer Treatment
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
